Posted by Michael Wonder on 15 May 2023
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
12 May 2023 - The study authors said the estimated costs to the program for seniors are conservative and spending on Leqembi might increase more than anticipated.
The new Alzheimer’s antibody treatment Leqembi could cost Medicare up to $5 billion per year, according to research published in a leading medical journal this week.
